Inventor · disambiguated record
Mauricio Berriel Diaz
Also filed as: BERRIEL DIAZ MAURICIO
4 granted patents·1 pending application·0 citations·filing 2014–2021
55Inventor score
Files withDEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES OEFFENTLICHEN RECHTS4HELMHOLTZ ZENTRUM MUENCHEN DEUTSCHES FORSCHUNGSZENTRUM GESUNDHEIT & UMWELT GMBH1
Top patents by PatentIndex Score
5 records- 0158US11053499B2Oligonucleotide sequences targeting transcription factor TSC22D4 for the treatment of insulin resistanceDEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES OEFFENTLICHEN RECHTS·Filed 2020·Granted Jul 6, 2021·0 cites·16 claims
- 0248US10676739B2Oligonucleotide sequences targeting transcription factor TSC22D4 for the treatment of insulin resistanceDEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES OEFFENTLICHEN RECHTS·Filed 2016·Granted Jun 9, 2020·0 cites·18 claims
- 0347US2023330111A1Active agent combination for treatment of cancerHELMHOLTZ ZENTRUM MUENCHEN DEUTSCHES FORSCHUNGSZENTRUM GESUNDHEIT & UMWELT GMBH·Filed 2021·Application pending·0 cites
- 0446US9879258B2Treatment of insulin resistance through inhibitors of transcription factor TSC22D4DEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES OEFFENTLICHEN RECHTS·Filed 2014·Granted Jan 30, 2018·0 cites·2 claims
- 0542US10041070B2MicroRNAs modulating the effect of glucocorticoid signalingDEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES OEFFENTLICHEN RECHTS·Filed 2014·Granted Aug 7, 2018·0 cites·9 claims
Join the waitlist — get patent alerts
Get an alert when Mauricio Berriel Diaz files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →